Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 7
Results: 28
Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1624, doi. 10.1177/10781552221094308
- By:
- Publication type:
- Article
Assessment of cisplatin-induced nephrotoxicity and its associated factors among cervical cancer patients in the leading tertiary hospital in Kenya.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1603, doi. 10.1177/10781552221119417
- By:
- Publication type:
- Article
Cost-effectiveness of biweekly cetuximab plus chemotherapy in first-line treatment for RAS wild-type metastatic colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1674, doi. 10.1177/10781552221114300
- By:
- Publication type:
- Article
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1613, doi. 10.1177/10781552221112320
- By:
- Publication type:
- Article
Pentosan polysulfate for the treatment of hemorrhagic cystitis after allogeneic hematopoietic cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1609, doi. 10.1177/10781552221105295
- By:
- Publication type:
- Article
Role of sacituzumab govitecan in solid tumors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1617, doi. 10.1177/10781552221092359
- By:
- Publication type:
- Article
Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1671, doi. 10.1177/10781552221078285
- By:
- Publication type:
- Article
Pericardial effusion with pembrolizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1664, doi. 10.1177/10781552221077974
- By:
- Publication type:
- Article
Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1659, doi. 10.1177/10781552221077956
- By:
- Publication type:
- Article
Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Reversible Cardiomyopathy after Rituximab Treatment in a Chronic Lymphocytic Leukemia Patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1650, doi. 10.1177/10781552221077422
- By:
- Publication type:
- Article
Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1645, doi. 10.1177/10781552221077418
- By:
- Publication type:
- Article
Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1641, doi. 10.1177/10781552221077038
- By:
- Publication type:
- Article
Successful administration of mitotane (O, p′-DDD) in pediatric oncology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1637, doi. 10.1177/10781552221076795
- By:
- Publication type:
- Article
Implementation of a clinical pharmacist-led service to optimize management of refractory chemotherapy-induced nausea and vomiting in adult hematology/oncology clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1499, doi. 10.1177/10781552211029702
- By:
- Publication type:
- Article
Retreatment with full-dose cytarabine in a patient with previous neurological toxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1634, doi. 10.1177/10781552221076777
- By:
- Publication type:
- Article
Oncologists' attitudes towards prophylaxis of cancer associated venous thromboembolism: A prospective, descriptive study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1560, doi. 10.1177/10781552211035704
- By:
- Publication type:
- Article
Use of nab -paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1594, doi. 10.1177/10781552211038677
- By:
- Publication type:
- Article
Analysis of chemical contamination by hazardous drugs with BD HD Check ® system in a tertiary hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1583, doi. 10.1177/10781552211038518
- By:
- Publication type:
- Article
Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1573, doi. 10.1177/10781552211038241
- By:
- Publication type:
- Article
Assessing febrile neutropenia outcomes in patients receiving primary versus secondary prophylactic G-CSF treatment therapy with intermediate neutropenic risk chemotherapy regimens.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1568, doi. 10.1177/10781552211035739
- By:
- Publication type:
- Article
Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1552, doi. 10.1177/10781552211035695
- By:
- Publication type:
- Article
Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1543, doi. 10.1177/10781552211035368
- By:
- Publication type:
- Article
Effects of piperacillin/tazobactam or cefepime on folinate dose in patients receiving high-dose methotrexate: A retrospective cohort study using Japanese administrative claims data.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1534, doi. 10.1177/10781552211034703
- By:
- Publication type:
- Article
Current status of biosimilars in Turkey: A survey among medical oncologists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1516, doi. 10.1177/10781552211031643
- By:
- Publication type:
- Article
What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1524, doi. 10.1177/10781552211031962
- By:
- Publication type:
- Article
Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1508, doi. 10.1177/10781552211030682
- By:
- Publication type:
- Article
Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1487, doi. 10.1177/10781552211023571
- By:
- Publication type:
- Article